Free Trial

BioCardia (BCDA) 10K Form and Latest SEC Filings 2026

BioCardia logo
$1.09 +0.02 (+1.87%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$1.10 +0.01 (+0.92%)
As of 05/14/2026 06:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest BioCardia SEC Filings & Recent Activity

BioCardia (NASDAQ:BCDA) has submitted 542+ documents to the U.S. Securities and Exchange Commission (SEC) since 2018. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form 8-K submitted on May 8, 2026.

Form 4
BioCardia, Inc. Reports Ownership Change on Apr. 29, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
BioCardia Files Current Report on May. 8, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
BioCardia Files Quarterly Report on Nov. 12, 2025

The 10-Q contains BioCardia's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

BioCardia SEC Filing History

Browse BioCardia's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/08/2026 7:00 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2026 6:40 PM
Altman Peter (1647542) Reporting
BioCardia (925741) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2026 7:00 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2026 4:04 PM
Altman Peter (1647542) Reporting
BioCardia (925741) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/20/2026 7:00 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2026 3:30 PM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2026 8:00 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2026 7:05 PM
Altman Peter (1647542) Reporting
BioCardia (925741) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2026 3:30 PM
BioCardia (925741) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/24/2026 3:31 PM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2026 5:02 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2026 7:01 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2026 8:15 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2026 4:47 PM
Altman Peter (1647542) Reporting
BioCardia (925741) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2026 7:00 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2026 4:03 PM
Altman Peter (1647542) Reporting
BioCardia (925741) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2025 4:13 PM
BioCardia (925741) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/17/2025 5:32 PM
Altman Peter (1647542) Reporting
BioCardia (925741) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2025 7:00 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2025 8:51 PM
BioCardia (925741) Issuer
Slosman Marvin (1796908) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 8:51 PM
BioCardia (925741) Issuer
Blank Andrew Scott (1789894) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 8:52 PM
BioCardia (925741) Issuer
STERTZER SIMON H (1031689) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 8:52 PM
BioCardia (925741) Issuer
Facteau Bill (1997664) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 8:52 PM
BioCardia (925741) Issuer
MOYES JAY M (1191062) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 8:53 PM
Allen Jim L. (1789590) Reporting
BioCardia (925741) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 8:54 PM
BioCardia (925741) Issuer
GILLIS EDWARD M (1241359) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 8:54 PM
BioCardia (925741) Issuer
McClung David (1686155) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 8:54 PM
Altman Peter (1647542) Reporting
BioCardia (925741) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2025 8:48 PM
BioCardia (925741) Issuer
Slosman Marvin (1796908) Reporting
Form 3
Initial statement of beneficial ownership of securities  
12/03/2025 7:00 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2025 3:07 PM
BioCardia (925741) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2025 3:10 PM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/10/2025 7:02 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2025 7:00 AM
BioCardia (925741) Filer
Form DEF 14A
10/30/2025 7:02 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2025 3:24 PM
BioCardia (925741) Filer
Form 10-Q/A
10/24/2025 3:16 PM
BioCardia (925741) Filer
Form 424B5
10/07/2025 3:15 PM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2025 7:00 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2025 4:13 PM
BioCardia (925741) Subject
INTRACOASTAL CAPITAL, LLC (1646799) Filed by
Form SCHEDULE 13G
09/24/2025 7:00 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Before you buy SpaceX shares, consider this alternative approach (Ad)

SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel

Discover the overlooked SpaceX IPO strategy before the June listing
09/23/2025 8:00 AM
Altman Peter (1647542) Reporting
BioCardia (925741) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2025 8:00 AM
BioCardia (925741) Issuer
Blank Andrew Scott (1789894) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2025 8:00 AM
BioCardia (925741) Issuer
STERTZER SIMON H (1031689) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2025 7:00 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2025 2:16 PM
BioCardia (925741) Subject
Lincoln Alternative Strategies LLC (2043812) Filed by
Form SCHEDULE 13G
09/19/2025 11:17 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2025 7:07 AM
BioCardia (925741) Filer
Form 424B4
09/18/2025 11:15 PM
BioCardia (925741) Filer
Form EFFECT
09/18/2025 8:15 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2025 6:00 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2025 5:01 AM
BioCardia (925741) Filer
Form S-1/A
09/16/2025 8:04 AM
BioCardia (925741) Filer
Form S-1
Registration statement under Securities Act of 1933  
08/25/2025 8:30 AM
Altman Peter (1647542) Reporting
BioCardia (925741) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2025 5:59 PM
Altman Peter (1647542) Reporting
BioCardia (925741) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2025 7:00 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2025 6:23 PM
Altman Peter (1647542) Reporting
BioCardia (925741) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025 6:21 PM
Altman Peter (1647542) Reporting
BioCardia (925741) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025 8:15 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2025 8:16 AM
BioCardia (925741) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/04/2025 6:07 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2025 11:15 PM
BioCardia (925741) Filer
Form EFFECT
07/17/2025 11:15 PM
BioCardia (925741) Filer
Form EFFECT
07/16/2025 7:45 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2025 4:21 PM
BioCardia (925741) Filer
Form S-3
Registration statement under Securities Act of 1933  
07/08/2025 4:03 PM
BioCardia (925741) Filer
Form 424B5
07/02/2025 8:01 PM
BioCardia (925741) Issuer
Blank Andrew Scott (1789894) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025 8:02 PM
BioCardia (925741) Issuer
STERTZER SIMON H (1031689) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025 8:02 PM
Altman Peter (1647542) Reporting
BioCardia (925741) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025 8:03 PM
BioCardia (925741) Issuer
McClung David (1686155) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025 11:35 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2025 7:00 AM
BioCardia (925741) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2025 7:55 PM
Altman Peter (1647542) Reporting
BioCardia (925741) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025 5:45 PM
Altman Peter (1647542) Reporting
BioCardia (925741) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025 5:18 PM
BioCardia (925741) Subject
Blank Andrew Scott (1789894) Filed by
Form SCHEDULE 13D
05/21/2025 10:37 AM
BioCardia (925741) Subject
Daly Joseph Patrick (1332596) Filed by
Form SCHEDULE 13D/A
05/16/2025 4:31 PM
Altman Peter (1647542) Reporting
BioCardia (925741) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

BioCardia SEC Filings - Frequently Asked Questions

BioCardia (BCDA) has submitted 542+ filings to the SEC since 2018. You can browse the complete history or filter by form type using the tools above.

BioCardia's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results.

The most recent filing was a Form 8-K submitted on May 8, 2026. This was a current report on a material business event.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:BCDA) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners